Effect of Pineapple Juice on the Pharmacokinetics of Celecoxib and Montelukast in Humans
NCT04374981 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2020-05-05
Summary
Pineapple (Ananas comosus) is a tropical fruit that is rich in antioxidents, enzymes and vitamins. It is used worldwide due to their anti-inflammatory and analgesic properties. The effect of pineapple Juice on the Pharmacokinetics of celecoxib and montelukast in Humans was studied.
Conditions
- Food-drug Interaction
Interventions
- DRUG
-
Celecoxib 100mg
Tablets
- DRUG
-
Montelukast 10mg
Tablets
Sponsors & Collaborators
-
Damanhour University
lead OTHER
Principal Investigators
-
Sally Helmy, PhD · Damanhour University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-07-01
- Primary Completion
- 2019-11-01
- Completion
- 2019-12-01
Countries
- Egypt
Study Locations
More Related Trials
-
Bioavailability Study of Colcrys® in Apple Juice
NCT01123395 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults
NCT04139824 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study PK Study With OXP005 and Naprosyn
NCT02351024 ·Status: COMPLETED ·Phase: PHASE1
-
Celecoxib (Celebrex) in the Management of Acute Renal Colic
NCT00304317 ·Status: WITHDRAWN ·Phase: PHASE4
-
Anti-inflammatory Agents and Cholesterol Metabolism
NCT01279395 ·Status: TERMINATED
-
Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums
NCT03012763 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
NCT01129245 ·Status: COMPLETED ·Phase: NA
-
Influence of Genotype of CYP2C9 on Clinical Efficacy and Pharmacokinetics of Piroxicam After Lower Third Molar Surgery
NCT02450487 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
NCT02146391 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
NCT00749385 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacogenetic and Pharmacokinetics of Naproxen and Associated Naproxen-esomeprazole
NCT03092193 ·Status: COMPLETED ·Phase: PHASE4
-
Naproxen Pharmacogenetic Study (Project 1, Aim 2)
NCT04449471 ·Status: UNKNOWN ·Phase: PHASE4
-
Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution
NCT02350296 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients
NCT01743300 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.
NCT04526197 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of AKB-6548 on the Pharmacokinetics of Celecoxib
NCT02502500 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dual Cyclooxygenase-2 and Carbonic Anhydrase Inhibition
NCT00780325 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics of SP-104
NCT05002946 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
NCT00807846 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E
NCT00907400 ·Status: COMPLETED ·Phase: PHASE1
-
Variability in Response to Non-steroidal Anti-inflammatory Drugs
NCT02502006 ·Status: TERMINATED ·Phase: PHASE1
-
Endobiotics for Phenotyping of Human Cytochrome P450 Enzymes
NCT04188028 ·Status: COMPLETED ·Phase: NA
-
Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
NCT06500793 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole
NCT05237297 ·Status: COMPLETED ·Phase: PHASE1
-
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
NCT02413203 ·Status: COMPLETED ·Phase: NA